Related Experiment Videos
Do self-perpetuating B lymphocytes drive human autoimmune disease?
J C Edwards1, G Cambridge, V M Abrahams
1Centre for Rheumatology, Department of Medicine, University College London, UK.
Immunology
|August 14, 1999
Summary
In rheumatoid arthritis, B lymphocytes may hijack immunological memory, driving autoantibody production. Depleting these B cells could potentially reverse autoimmune diseases.
Area of Science:
- Immunology
- Autoimmunity
- Rheumatoid Arthritis
Background:
- Immunological memory is typically mediated by T lymphocytes.
- In rheumatoid arthritis, B lymphocytes appear to subvert T-cell control.
- The role of B cells in other autoimmune diseases is under investigation.
Purpose of the Study:
- To explore the potential role of B lymphocytes in misappropriating immunological memory in human autoantibody-associated diseases.
- To investigate the mechanisms by which autoantibodies may drive their own production.
- To assess the therapeutic potential of B-lymphocyte-depleting agents in autoimmunity.
Main Methods:
- Review of existing observations and literature on immunological memory and B-cell function in autoimmune diseases.
- Analysis of potential mechanisms for self-perpetuating B-lymphocyte activity.
- Consideration of the implications of B-cell-driven autoantibody production.
Main Results:
- Evidence suggests B lymphocytes may hijack immunological memory in rheumatoid arthritis.
- A common feature in human autoantibody-associated diseases may be the misappropriation of immunological memory by B lymphocytes.
- Autoantibodies can potentially drive their own continuous production.
Conclusions:
- B lymphocytes may play a central role in driving autoimmunity by controlling immunological memory.
- Targeting B lymphocytes with depleting agents offers a potential therapeutic strategy for reversing autoimmune conditions.
- Further research into B-cell-mediated autoimmunity is warranted.